DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
Clinical trial NCT05722886 · RECRUITING
Trial details
- NCT number
- NCT05722886
- Sponsor
- Cancer Research UK
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2029-10-01
- Enrollment
- 825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.